Mather Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-750
Closed -$17.8K 2131
2024
Q2
$17.8K Buy
+750
New +$17.8K ﹤0.01% 1290